Nu Skin Enterprises, Inc. (NUS)
Consumer Defensive
- Fundamental
- 2
- Sentiment
- 2
- Technical
- 1
Do Nothing: fundamentalScore 2 and qualitativeScore 2 both fail the required floor of 3, and 20-day average dollar volume of ~$2.38M is below the $5M liquidity floor; both entry types were considered — no trade plan was built because the hard blocks suppress Step 03, and the chart read (price 4.03 below the full MA/EMA stack with MACD -0.21) would additionally bar a pullback/oversold limit as countertrend under the trend-alignment gate.
Company overview
Nu Skin Enterprises, Inc. is a global company focused on beauty and wellness products. Its offerings include advanced skincare systems, nutritional supplements, and weight management programs. The company operates through a network of independent distributors and e-commerce, with a significant presence in Mainland China.
Fundamental
weakNu Skin's fundamentals are weak, with declining revenue, negative cash flow, and earnings quality issues.
Nu Skin's reported results are one-time-item driven in both directions: FY2025's $160.2M profit came almost entirely from the $176.2M pre-tax Mavely sale gain, while the trailing twelve months' $(234.2)M loss is almost entirely a $78.9M non-cash goodwill impairment plus a $167.5M full U.S. deferred-tax valuation allowance. On the recurring picture the business remains modestly profitable (9M 2026 adjusted operating income $42.6M, adjusted EPS $0.44) and its balance sheet is intact ($164.9M cash, roughly $87.5M net debt, covenants compliant after the March 2026 refinancing), but revenue has now declined double digits for a fourth consecutive year (-14.6% in Q3 2026, customers -18%), gross margin has compressed to 65.0%, and free cash flow has turned negative. Deeply cheap on assets and adjusted earnings, but the operating trend and the fully reserved U.S. tax assets make it a value trap rather than a short-term buy.
Sentiment
weakSentiment is bearish following a significant earnings miss and downward forecast revisions.
Dominant driver is the announced 2026-11-05 Q3 earnings miss (adjusted EPS $0.10 vs $0.21 consensus, revenue lagging estimates) with forecast revisions already moving lower — a bearish, only partially digested catalyst. The measured sentiment delta is flat (baseline polarity_score ≈ -0.10 → scoring ≈ -0.07), retail is unavailable because Reddit access is blocked, and the Red-Flag Screen is clean with no cap applied; with no forward-dated catalyst inside 30 days, the setup is weak post-event digestion rather than an actionable long.
Technical
very weakThe stock is in a downtrend, trading below all major moving averages with weak momentum indicators.
Chart scores 1/5 — broken structure: price 4.03 sits below SMA20 4.56, SMA50 4.68, SMA200 6.06, EMA9 4.22, EMA21 4.46, WMA9 4.13, WMA21 4.42 and DEMA14 4.08, with MACD -0.21 below its -0.12 signal (histogram -0.08) and RSI14 36.9 weak rather than washed out. The only constructive feature is a two-session hold above the 2026-11-12 year low 3.87 (closes 4.01 then 4.03) with Williams %R -87.5 oversold — a bounce attempt inside a primary downtrend, not a reversal. Beyond the chart, the trade is disqualified: fundamentalScore 2 and qualitativeScore 2 both fail the required >=3 floors, and 20-day average dollar volume of ~$2.38M is below the $5M liquidity floor.
You’re looking at 2026-11-14 — more than 2 trading days ago.
Subscribers saw this then, and see today’s score, verdict and trade plan now.
More Consumer Defensive
Not financial advice. For informational and educational purposes only.

